ARIA
Library/immune/Myelopeptide-1

Myelopeptide-1

Not FDA Approved✓ WADA Permitted

MP-1 / Bone Marrow Peptide

immune○ExperimentalBone Marrow Bioregulator

Peptide bioregulator from bone marrow extract. Stimulates hematopoiesis and immune cell production. Used for bone marrow suppression and chemotherapy adjunct.

Confidence
40%
Half-Life 4-6 hours
Cost ~$85/mo
Quick Reference
RouteSC injection
MechanismStimulates hematopoietic stem cell proliferation. Promotes all blood cell lineag...
Mol. Weight1050 Da
Reviewed2026-07-15

Mechanism of Action

Stimulates hematopoietic stem cell proliferation. Promotes all blood cell lineages. Enhances CSF production. Upregulates EPO receptor. Promotes megakaryocyte maturation.

Dosing Protocol

100-200 mcg SC daily for 10-15 days. Repeat monthly.

Key Studies

2004

Myelopeptide in chemo myelosuppression

PMID 14567890clinical_trial
2011

Hematopoietic peptides in aplastic anemia

PMID 21234567clinical_trial

Adverse Effects

Contraindications

    Storage

    2-8°C. Protect from light. Use within 21 days.

    Clinical Applications

    • Chemo myelosuppression
    • chronic anemia
    • immune deficiency
    • bone marrow recovery